Purine-based dual inhibitors of CDK2 and CDK7
Cyclin-Dependent Kinases (CDKs) play a fundamental role in eukaryotic cell cycle progression, particularly at cell cycle checkpoints, and are therefore important targets for anticancer drug discovery. Activation of CDK2 in complex with Cyclin A regulates entry into S phase of the eukaryotic cell cyc...
Main Author: | Meschini, Elisa |
---|---|
Published: |
University of Newcastle Upon Tyne
2011
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.566914 |
Similar Items
-
Investigations of G2/M decatenation checkpoint control, using the DNA topoisomerase II inhibitor ICRF-193
by: Feeney, Katherine M.
Published: (2007) -
Identification and characterization of a LIF-STAT3/Activin-Smad2/3 dual responsive pluripotent stem cell state
by: Chang, Kuo-Hsuan
Published: (2010) -
The p97 cofactors UBXN7 and UBXN8 interact with and modulate the function of cullin-RING complexes and Fanconi anaemia proteins FANCD2/FANCI, respectively
by: Bandau, Susanne
Published: (2014) -
Dynamics of cell cycle perturbations and cell death by topoisomerase inhibitors in human B-lymphoma cell lines
by: Chin, S.-F.
Published: (1997) -
Expression of the inwardly rectifying potassium ion channel, Kir2.2, and its modulating receptor, NK-1 R, in rat brain
by: Stonehouse, Anthony Harold
Published: (1999)